Literature DB >> 6155736

IgG subclasses in human gamma-globulin preparations for intravenous use and their reactivity with staphylococcus protein A.

F Skvaril, B Roth-Wicky, S Barandun.   

Abstract

In two of four non-enzymatically treated gamma-globulin preparations C Immunoglobulin Schura, Immunoglobulin SRK), the distribution of IgG subclasses was found to be close to that of normal human serum. In two other preparations (sulphonated and beta-propiolactone-treated) IgG3 was not detectable by means of appropriate antiserum. The IgG residual portion of plasmin-treated gamma-globulin was enriched in IgG2, while IgG3 was absent. In affinity chromatography on protein A Sepharose, IgG3 in the unbound and IgG1, IgG2 and IgG4 in the bound fractions were found in Immunoglobulins Schura and SRK. In the sulphonated preparation no IgG was found in the unbound fraction, while IgG1, IgG2 and IgG4 were eluted from the bound fraction. In beta-propiolactone-treated gamma-globulin IgG1, IgG2 and IgG4 were present in both fractions. The testing of reactivity of IgG subclasses with Staphylococcus protein A can supply important information about the state of the Fc part in immunoglobulin preparations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155736     DOI: 10.1111/j.1423-0410.1980.tb02342.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  13 in total

Review 1.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

2.  A human IgG 3 is opsonic in vitro against type III group B streptococci.

Authors:  J S Kim; K S Kim; C A Wass; J A Short; D C Heiner
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

3.  Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

Authors:  O Scharf; H Golding; L R King; N Eller; D Frazier; B Golding; D E Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  The capacity of various types of immunoglobulin for intravenous use to interact with Fc receptors of human monocytes and macrophages.

Authors:  T W Jungi; J Eiholzer; P G Lerch; S Barandun
Journal:  Blut       Date:  1986-10

5.  Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence.

Authors:  C S Munro; P J Stanley; P J Cole
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Membrane receptors for the IgG4 subclass on human basophils and mast cells.

Authors:  T Nakagawa; A L de Weck
Journal:  Clin Rev Allergy       Date:  1983-06

7.  Quality control in the production of an immunoglobulin for intravenous use.

Authors:  A Gardi
Journal:  Blut       Date:  1984-06

8.  Characterization of the subclasses and light chain types of IgG antibodies to rubella.

Authors:  F Skvaril; U Schilt
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency.

Authors:  A Morell; E Muehlheim; U Schaad; F Skvaril; E Rossi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

10.  Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.

Authors:  W P Kaschka; R Hilgers; F Skvaril
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.